HeartSciences Inc. Files Additional Definitive Proxy Soliciting Materials
HeartSciences Inc. submitted a Form DEFA14A filing with the SEC on November 4, 2026.
Filings · News reference
HEARTSCIENCES INC. PROSPECTUS $200,000,000 Common Stock Preferred Stock Debt Securities Warrants Rights Units This prospectus will allow HeartSciences Inc. (the "Company", "we", "us" or
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
HeartSciences Inc. submitted a Form DEFA14A filing with the SEC on November 4, 2026.
Andrew Simpson filed a Schedule 13D/A with the SEC regarding HeartSciences Inc. on October 23, 2026, indicating a change in beneficial ownership.
HeartSciences Inc. has filed its definitive proxy statement with the SEC regarding its previously announced business combination with Fortitude Mining Holdings, Inc.
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or